Pioglitazone
- Product NDC
- 70934-619
- 11-digit product format
- 709340619
- Labeler code
- 70934
- Product ID
- 70934-619_acaec714-725a-474d-e053-2995a90a1a0d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA077210
- Marketing category
- ANDA
- Marketing start
- 2020-07-30
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-619-30 | 70934061930 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-619-30) | 30 tablet | 2020-07-30 | 0000-00-00 | No | No | Current |